Category: Chile

Preprint: MU B.1.621 the most resistant variant to convalescent and vaccinated sera to date

Here, we demonstrate that the Mu variant is highly resistant to sera from COVID-19 convalescents and BNT162b2-vaccinated individuals. Direct comparison of different SARS-CoV-2 spike proteins revealed that Mu spike is more resistant to serum-mediated neutralization than all other currently recognized variants of interest (VOI) and concern (VOC).… ...More...

Coronaheadsup.com America, Argentina, B.1.621, Chile, Colombia, Coronavirus, Infection, MU, Peru, Pfizer/Biontech, Sinovac, Vaccine, Vaccine Breakthrough, Variants

Preprint: Infectivity and immune escape of the new coronavirus variant of interest C.37 Lambda

“We also observed that the spike protein of the Lambda variant presented increased infectivity when compared with the spike protein of the Alpha and Gamma variants, both of them with reported increased infectivity and transmissibility.… ...More...

Coronaheadsup.com Alpha, America, Argentina, Astrazeneca, B.1.1.7, Chile, CoronaVac, Coronavirus, D614G, F490S, Gamma, Health, Infection, L452Q, Lambda, Mexico, Mutation, P.1, Peru, Pfizer/Biontech, Sinovac, Transmission, Vaccine, Vaccine Breakthrough

Preprint: The emergence of Sars-CoV-2 coronavirus variant Lambda C.37 in South America

We report the emergence of a novel lineage of SARS-CoV-2 in South America, termed C.37. It presents seven nonsynonymous mutations in the Spike gene (Δ247-253, G75V, T76I, L452Q, F490S, T859N) and a deletion in the ORF1a gene (Δ3675-3677) also found in variants of concern (VOCs) Alpha, Beta, and Gamma.… ...More...

Coronaheadsup.com Alpha, America, Argentina, Beta, C-37, Chile, Colombia, Coronavirus, Gamma, Health, Infection, L452Q, Lambda, Mexico, Mutation, Peru, Transmission, USA, Variants